{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Visual+Function+Tests&page=27", "query": { "intervention": "Visual Function Tests", "page": 27 }, "page_size": 10 }, "pagination": { "page": 27, "page_size": 10, "total_count": 670, "total_pages": 67, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Visual+Function+Tests&page=28&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Visual+Function+Tests&page=26&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T19:00:10.027Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06922942", "title": "MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "MSCopilot Flower mobile application", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ad scientiam", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2025-08-12", "completion_date": "2026-03-01", "has_results": false, "last_update_posted_date": "2025-10-02", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 4, "location_summary": "New Orleans, Louisiana • St Louis, Missouri • Oklahoma City, Oklahoma + 1 more", "locations": [ { "city": "New Orleans", "state": "Louisiana" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06922942" }, { "nct_id": "NCT07191327", "title": "Testing Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Posterior Cortical Atrophy" ], "interventions": [ { "name": "HD-tDCS sessions", "type": "DEVICE" }, { "name": "Sham HD-tDCS sessions", "type": "DEVICE" }, { "name": "HD-tDCS sessions - Open-label (after randomized treatment)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 50, "start_date": "2026-01-28", "completion_date": "2029-07-31", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07191327" }, { "nct_id": "NCT07613333", "title": "Postpartum Exercise Intervention", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postpartum", "Neuromuscular Adaptations", "Abdominal Muscles", "Pelvic Floor Dysfunctions", "Physical Activity" ], "interventions": [ { "name": "Progressive exercise", "type": "OTHER" }, { "name": "Active Straight Leg Raise Test", "type": "DIAGNOSTIC_TEST" }, { "name": "Active Straight Leg Raise Fatigue Task", "type": "OTHER" }, { "name": "Lower Extremity Strength Testing", "type": "OTHER" }, { "name": "Ultrasound imaging of abdominal wall", "type": "DIAGNOSTIC_TEST" }, { "name": "Pelvic Floor Muscle Strength Testing", "type": "OTHER" }, { "name": "Pelvic Floor Muscle Endurance Testing", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "Carroll University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 50, "start_date": "2026-02-19", "completion_date": "2028-08", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 1, "location_summary": "Waukesha, Wisconsin", "locations": [ { "city": "Waukesha", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT07613333" }, { "nct_id": "NCT07823491", "title": "Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Resectable Liposarcoma", "Resectable Soft Tissue Sarcoma", "Resectable Undifferentiated Pleomorphic Sarcoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Intensity-Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Surgical Procedure", "type": "PROCEDURE" }, { "name": "Transthoracic Echocardiography Test", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "RADIATION", "BIOLOGICAL", "OTHER" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 228, "start_date": "2026-12-01", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07823491" }, { "nct_id": "NCT03851458", "title": "Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Overweight", "Obesity" ], "interventions": [ { "name": "Initial in-person individual diet and exercise counseling (N vs. Y)", "type": "BEHAVIORAL" }, { "name": "Thrice weekly diet and exercise text messages (N vs. Y)", "type": "BEHAVIORAL" }, { "name": "Weekly telephone support (N vs. Y)", "type": "BEHAVIORAL" }, { "name": "Self-monitoring tools (N vs. Y) (for diet and weight)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1785, "start_date": "2015-05-05", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-07-06", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03851458" }, { "nct_id": "NCT05540535", "title": "Dual-Task Cost in Bilateral Hearing Loss", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bilateral Hearing Loss", "Healthy Aging" ], "interventions": [ { "name": "Gait assessment", "type": "OTHER" }, { "name": "Cognitive assessment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "New York University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 67, "start_date": "2022-02-01", "completion_date": "2024-11-22", "has_results": true, "last_update_posted_date": "2025-01-13", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05540535" }, { "nct_id": "NCT06606925", "title": "Determining Which Regions of the Brain Are Active During Flight Simulation at Separate Timepoints During Training", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cognitive Performance" ], "interventions": [ { "name": "fMRI with virtual reality flight simulator", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "The Geneva Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "54 Years", "sex": "ALL", "summary": "18 Years to 54 Years" }, "enrollment_count": 35, "start_date": "2023-09-19", "completion_date": "2026-07-10", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06606925" }, { "nct_id": "NCT03757039", "title": "Multifocal Visual Performance Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Presbyopia" ], "interventions": [ { "name": "Multifocal soft contact lenses", "type": "DEVICE" }, { "name": "Progressive addition lens spectacles", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "38 Years", "maximum_age": "58 Years", "sex": "ALL", "summary": "38 Years to 58 Years" }, "enrollment_count": 42, "start_date": "2018-12-16", "completion_date": "2019-03-06", "has_results": true, "last_update_posted_date": "2020-03-25", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03757039" }, { "nct_id": "NCT07278856", "title": "Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Follicular Helper T-Cell Lymphoma", "Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type", "Follicular Helper T-Cell Lymphoma, Follicular-Type", "Follicular Helper T-Cell Lymphoma, Not Otherwise Specified", "Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "Peripheral T-Cell Lymphoma, Not Otherwise Specified" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "FDG-Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Filgrastim", "type": "BIOLOGICAL" }, { "name": "Fludeoxyglucose F-18", "type": "OTHER" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Pegfilgrastim", "type": "BIOLOGICAL" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Ruxolitinib Phosphate", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2025-12-16", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07278856" }, { "nct_id": "NCT03640221", "title": "Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Ertugliflozin", "type": "DRUG" }, { "name": "Hydrochlorothiazide 12.5mg", "type": "DRUG" }, { "name": "Microneurography", "type": "DEVICE" }, { "name": "SKNA recordings", "type": "OTHER" }, { "name": "Static Handgrip", "type": "OTHER" }, { "name": "Post-handgrip forearm vascular occlusion", "type": "OTHER" }, { "name": "Testing of the Arterial Baroreflex Function", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "35 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2018-09-01", "completion_date": "2020-08-31", "has_results": false, "last_update_posted_date": "2020-01-14", "last_synced_at": "2026-10-31T19:00:10.027Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03640221" } ] }